[go: up one dir, main page]

PL3569697T3 - Terapia komórkami macierzystymi w patologiach endometrium - Google Patents

Terapia komórkami macierzystymi w patologiach endometrium

Info

Publication number
PL3569697T3
PL3569697T3 PL19169309T PL19169309T PL3569697T3 PL 3569697 T3 PL3569697 T3 PL 3569697T3 PL 19169309 T PL19169309 T PL 19169309T PL 19169309 T PL19169309 T PL 19169309T PL 3569697 T3 PL3569697 T3 PL 3569697T3
Authority
PL
Poland
Prior art keywords
stem cell
cell therapy
endometrial
pathologies
endometrial pathologies
Prior art date
Application number
PL19169309T
Other languages
English (en)
Inventor
Carlos Simon
Javier SANTAMARIA
Antonio PELLICER
Irene CERVELLO
Original Assignee
Asherman Therapy, S.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asherman Therapy, S.L. filed Critical Asherman Therapy, S.L.
Publication of PL3569697T3 publication Critical patent/PL3569697T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
PL19169309T 2014-06-17 2015-06-05 Terapia komórkami macierzystymi w patologiach endometrium PL3569697T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201462013121P 2014-06-17 2014-06-17
PCT/IB2015/001715 WO2015193737A1 (en) 2014-06-17 2015-06-05 Stem cell therapy in endometrial pathologies
EP19169309.2A EP3569697B8 (en) 2014-06-17 2015-06-05 Stem cell therapy in endometrial pathologies
EP15781411.2A EP3158057B1 (en) 2014-06-17 2015-06-05 Stem cell therapy in endometrial pathologies

Publications (1)

Publication Number Publication Date
PL3569697T3 true PL3569697T3 (pl) 2022-07-04

Family

ID=54329860

Family Applications (3)

Application Number Title Priority Date Filing Date
PL19169309T PL3569697T3 (pl) 2014-06-17 2015-06-05 Terapia komórkami macierzystymi w patologiach endometrium
PL15781411T PL3158057T3 (pl) 2014-06-17 2015-06-05 Terapia komórkami macierzystymi w patologiach endometrium
PL22150013.5T PL4012023T3 (pl) 2014-06-17 2015-06-05 Terapia komórkami macierzystymi w patologiach endometrium

Family Applications After (2)

Application Number Title Priority Date Filing Date
PL15781411T PL3158057T3 (pl) 2014-06-17 2015-06-05 Terapia komórkami macierzystymi w patologiach endometrium
PL22150013.5T PL4012023T3 (pl) 2014-06-17 2015-06-05 Terapia komórkami macierzystymi w patologiach endometrium

Country Status (22)

Country Link
US (1) US11129851B2 (pl)
EP (3) EP3158057B1 (pl)
JP (2) JP6920062B2 (pl)
CN (2) CN116747241A (pl)
AU (1) AU2015275798B2 (pl)
BR (1) BR112016029558A2 (pl)
CA (1) CA2952559C (pl)
CY (2) CY1122615T1 (pl)
DK (2) DK3158057T3 (pl)
ES (3) ES2910306T3 (pl)
HR (3) HRP20220419T1 (pl)
HU (3) HUE044823T2 (pl)
LT (2) LT3569697T (pl)
MX (1) MX377300B (pl)
PL (3) PL3569697T3 (pl)
PT (2) PT3158057T (pl)
RS (3) RS59210B1 (pl)
RU (1) RU2725006C2 (pl)
SI (2) SI3569697T1 (pl)
SM (3) SMT202200155T1 (pl)
TR (1) TR201910410T4 (pl)
WO (1) WO2015193737A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010010201A1 (es) 2008-07-22 2010-01-28 Equipo Ivi Investigacion Sl Perfil de expresion genetica como marcador de la receptividad endometrial
TR201819859T4 (tr) 2012-06-06 2019-01-21 Fundacio Inst De Recerca Biomedica Irb Barcelona Akciğer kanseri metastazının tanısı ve prognozu için yöntem.
CN104995313A (zh) 2012-10-12 2015-10-21 生物运动有限公司 使用c-maf的前列腺癌转移的诊断、预后和治疗的方法
US10119171B2 (en) 2012-10-12 2018-11-06 Inbiomotion S.L. Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
US20160040247A1 (en) 2013-03-15 2016-02-11 Fundació Institut De Recerca Biomèdica (Irb Barcelona) Method for the diagnosis, prognosis, and tratment of cancer metastasis
PL3569697T3 (pl) 2014-06-17 2022-07-04 Asherman Therapy, S.L. Terapia komórkami macierzystymi w patologiach endometrium
CA3028422A1 (en) * 2016-06-23 2017-12-28 Tithon Biotech, Inc. Cells expressing parathyroid hormone 1 receptor and uses thereof
RU2699029C1 (ru) * 2018-12-10 2019-09-03 Частное образовательное учреждение дополнительного профессионального образования "Академия медицинского образования имени Федора Ивановича Иноземцева" (ЧОУ ДПО "Академия медицинского образования им. Ф.И. Иноземцева") Способ использования мезенхимальных стволовых клеток для улучшения состояния рубца на матке
RU2741621C1 (ru) * 2020-09-25 2021-01-28 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации Способ лечения внутриматочных синехий
KR20230015832A (ko) 2021-07-23 2023-01-31 차의과학대학교 산학협력단 분리된 미토콘드리아를 유효성분으로 포함하는 아셔만 증후군 예방 또는 치료용 약학 조성물

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2054197A1 (en) 1989-05-05 1990-11-06 Christopher O'neill Fertility enhancement
US6979533B2 (en) 1992-06-12 2005-12-27 The Trustees Of The University Of Pennsylvania Determination of endometrial receptivity toward embryo implantation
CA2203718A1 (en) 1997-04-25 1998-10-25 University Of British Columbia Cadherin-11 as an indicator of viable pregnancy
IL127896A0 (en) 1998-12-31 1999-10-28 Gail Laster A novel treatment for preeclampsia and related diseases
EP1255851A4 (en) 2000-03-08 2004-03-31 Harvey J Kliman METHODS FOR DIAGNOSING AND MONITORING ENDOMETRIAL GLANDULAR DEVELOPMENT
JP2004504275A (ja) 2000-05-24 2004-02-12 シエーリング　アクチエンゲゼルシャフト フィブリン−１の医薬用途
US6780594B2 (en) 2000-09-25 2004-08-24 Schering Aktiengesellschaft Method for in vitro diagnosis of endometriosis
AUPR673001A0 (en) 2001-07-31 2001-08-23 Prince Henry's Institute Of Medical Research Pregnancy-related enzyme activity
DE10139874A1 (de) 2001-08-10 2003-04-30 Schering Ag Humane Mater-Proteine
GB0201284D0 (en) 2002-01-21 2002-03-06 Isis Innovation Screening methods for contraceptive and fertility agents
US20030186300A1 (en) 2002-03-20 2003-10-02 Ali Akoum Methods and products for modulation of reproductive processes and for diagnosis, prognostication and treatment of related conditions
US20040005612A1 (en) 2002-05-14 2004-01-08 Giudice Linda C. Endometrial genes in endometrial disorders
DK1525215T3 (da) 2002-08-02 2007-01-15 Schering Ag Modulatorer for receptoren for progesteron med forhöjet anti-gonadotrop aktivitet til fertilitetskontrol hos kvinder og ved terapi til erstatning af hormoner
DE10236405A1 (de) 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
EP1579007B1 (de) 2002-12-21 2015-05-27 Universität Leipzig Verfahren und mittel zur bestimmung von bestimmten zuständen bzw. veränderungen im uterusepithel und im epithel anderer organe
WO2005018796A1 (en) 2003-08-21 2005-03-03 Pamgene B.V. Microarray support for bioprobe synthesis
CN1863905A (zh) 2003-09-08 2006-11-15 得克萨斯系统大学董事会 通过用前列腺素或前列腺素类似物补充培养基加强体外胚发育的方法以及组合物
WO2005026324A2 (en) 2003-09-08 2005-03-24 The Board Of Regents Of The University Of Texas System Method and composition for enhancing in vitro embryo development by supplementing culture medium with prostaglandin or a prostaglandin analog
ATE476525T1 (de) 2003-12-23 2010-08-15 Mount Sinai Hospital Corp Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern
US20080014172A1 (en) 2004-05-28 2008-01-17 Applied Research Systems Ars Holding N.V. Use of Il-17 in the Treatment of Fertility-Related Disorders
JP2009531705A (ja) * 2006-03-31 2009-09-03 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 超短ｔ２＊緩和測定法を用いた細胞測定のためのシステムおよび方法
JP2007278750A (ja) 2006-04-04 2007-10-25 Ono Pharmaceut Co Ltd プロスタグランジン類及びその類縁体の定量方法
US20120269774A1 (en) * 2006-09-21 2012-10-25 Medistem Laboratories, Inc Allogeneic stem cell transplants in non-conditioned recipients
GB0703683D0 (en) * 2007-02-26 2007-04-04 Ark Therapeutics Ltd The treatment of complications in pregnancy
US9259233B2 (en) * 2007-04-06 2016-02-16 Hologic, Inc. Method and device for distending a gynecological cavity
US8673850B2 (en) 2008-05-30 2014-03-18 Institut De Recherches Cliniques De Montreal PCSK9 inhibitors and methods of use thereof
WO2010010201A1 (es) 2008-07-22 2010-01-28 Equipo Ivi Investigacion Sl Perfil de expresion genetica como marcador de la receptividad endometrial
WO2013166281A1 (en) * 2012-05-02 2013-11-07 Cedars-Sinai Medical Center Bi-functional compositions for targeting cells to diseased tissues and methods of using same
EP2348318A1 (en) 2010-01-21 2011-07-27 Equipo Ivi Investigación, S.L. Diagnostic method for endometrial receptivity
JP6204919B2 (ja) 2011-10-21 2017-09-27 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 調節性過排卵誘起後の患者の子宮内膜受容性を評価するための方法
WO2013081554A1 (en) 2011-11-30 2013-06-06 Agency For Science, Technology And Research Gm1 ganglioside to annexin v microparticle polypeptide ratio for biological monitoring
JP5937756B2 (ja) 2012-06-27 2016-06-22 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 特定期間以内の妊娠高血圧腎症発症を除外するためにｓＦｌｔ−１／ＰｌＧＦ比またはエンドグリン／ＰｌＧＦ比を適用する手段および方法
RU2515475C1 (ru) 2012-11-15 2014-05-10 Федеральное государственное бюджетное учреждение науки ИНСТИТУТ ЦИТОЛОГИИ РОССИЙСКОЙ АКАДЕМИИ НАУК Способ стимуляции образования децидуальной оболочки эндометрия в эксперименте
CA2943284A1 (en) 2014-03-21 2015-11-05 Igenomix S.L. Early detection of preeclampsia
PL3569697T3 (pl) 2014-06-17 2022-07-04 Asherman Therapy, S.L. Terapia komórkami macierzystymi w patologiach endometrium

Also Published As

Publication number Publication date
CY1125938T1 (el) 2024-02-16
EP4012023C0 (en) 2024-05-15
BR112016029558A2 (pt) 2017-08-22
HUE067463T2 (hu) 2024-10-28
CY1122615T1 (el) 2021-03-12
AU2015275798B2 (en) 2021-03-25
RU2017101147A (ru) 2018-07-17
SMT202200155T1 (it) 2022-05-12
US20170128492A1 (en) 2017-05-11
ES2910306T3 (es) 2022-05-12
MX2016016756A (es) 2017-11-02
CN116747241A (zh) 2023-09-15
JP2017522288A (ja) 2017-08-10
EP4012023B1 (en) 2024-05-15
MX377300B (es) 2025-03-07
HRP20240798T1 (hr) 2024-09-27
EP3158057B1 (en) 2019-04-17
EP4012023A1 (en) 2022-06-15
SMT201900400T1 (it) 2019-09-09
LT3569697T (lt) 2022-04-25
DK3569697T3 (da) 2022-04-04
SI3569697T1 (sl) 2022-05-31
ES2736117T3 (es) 2019-12-26
PL3158057T3 (pl) 2020-05-18
EP3158057A1 (en) 2017-04-26
PL4012023T3 (pl) 2024-09-02
PT3569697T (pt) 2022-05-02
EP3569697A1 (en) 2019-11-20
HRP20191240T1 (hr) 2019-11-01
CA2952559C (en) 2023-01-24
EP3569697B1 (en) 2022-01-05
ES2983444T3 (es) 2024-10-23
SMT202400270T1 (it) 2024-07-09
RU2017101147A3 (pl) 2019-02-06
HRP20220419T1 (hr) 2022-05-27
US11129851B2 (en) 2021-09-28
CA2952559A1 (en) 2015-12-23
JP6920062B2 (ja) 2021-08-18
RS63093B1 (sr) 2022-04-29
AU2015275798A1 (en) 2017-02-02
RU2725006C2 (ru) 2020-06-29
HUE044823T2 (hu) 2019-11-28
PT3158057T (pt) 2019-07-19
TR201910410T4 (tr) 2019-08-21
HUE058328T2 (hu) 2022-07-28
EP3569697B8 (en) 2022-04-27
JP2020138984A (ja) 2020-09-03
LT3158057T (lt) 2019-09-25
CN107073040A (zh) 2017-08-18
RS59210B1 (sr) 2019-10-31
WO2015193737A1 (en) 2015-12-23
SI3158057T1 (sl) 2019-10-30
RS65719B1 (sr) 2024-08-30
DK3158057T3 (da) 2019-07-29

Similar Documents

Publication Publication Date Title
IL274903A (en) cell
SMT201900400T1 (it) Terapia con cellule staminali in patologie endometriali
PL3134724T3 (pl) Komórka elektrochemiczna
SG11201607925SA (en) Improved stem cell composition
SG11201610831PA (en) Lithium-sulphur battery
PT3157504T (pt) Composições estimuladoras das células estaminais
SG11201609055RA (en) Integrated single cell sequencing
GB201411985D0 (en) Battery
HUE042287T2 (hu) Lítium-kén cella
SG10201403640XA (en) Stem cells
HK40099394A (en) Stem cell therapy in endometrial pathologies
GB201406700D0 (en) Cervix cells
GB201416493D0 (en) Polypeptides for use in therapy
GB201416750D0 (en) Cell preparation
ZA201505928B (en) Built in gas-fired braii unit
GB201406606D0 (en) Improvements in transformer design
GB201411798D0 (en) Electrochemical cell
GB201410934D0 (en) T cell